These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36244310)

  • 41. Efficacious Preclinical Repurposing of the Nucleoside Analogue Didanosine against COVID-19 Polymerase and Exonuclease.
    Rabie AM
    ACS Omega; 2022 Jun; 7(25):21385-21396. PubMed ID: 35785294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16.
    Klima M; Khalili Yazdi A; Li F; Chau I; Hajian T; Bolotokova A; Kaniskan HÜ; Han Y; Wang K; Li D; Luo M; Jin J; Boura E; Vedadi M
    Protein Sci; 2022 Sep; 31(9):e4395. PubMed ID: 36040262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Docking Studies to Identify Promising Natural Inhibitors Targeting SARS-CoV-2 Nsp10-Nsp16 Protein Complex.
    Bhardwaj A; Sharma S; Singh SK
    Turk J Pharm Sci; 2022 Feb; 19(1):93-100. PubMed ID: 35227055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential COVID-19 Therapies from Computational Repurposing of Drugs and Natural Products against the SARS-CoV-2 Helicase.
    Piplani S; Singh P; Winkler DA; Petrovsky N
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiviral Drug Discovery for the Treatment of COVID-19 Infections.
    Ng TI; Correia I; Seagal J; DeGoey DA; Schrimpf MR; Hardee DJ; Noey EL; Kati WM
    Viruses; 2022 May; 14(5):. PubMed ID: 35632703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0.
    Gervasoni S; Vistoli G; Talarico C; Manelfi C; Beccari AR; Studer G; Tauriello G; Waterhouse AM; Schwede T; Pedretti A
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computational drug repurposing study of the RNA binding domain of SARS-CoV-2 nucleocapsid protein with antiviral agents.
    Tatar G; Ozyurt E; Turhan K
    Biotechnol Prog; 2021 Mar; 37(2):e3110. PubMed ID: 33314794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conserved coronavirus proteins as targets of broad-spectrum antivirals.
    Melo-Filho CC; Bobrowski T; Martin HJ; Sessions Z; Popov KI; Moorman NJ; Baric RS; Muratov EN; Tropsha A
    Antiviral Res; 2022 Aug; 204():105360. PubMed ID: 35691424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring the Potential Pharmacological Mechanism of Hesperidin and Glucosyl Hesperidin against COVID-19 Based on Bioinformatics Analyses and Antiviral Assays.
    Huang Y; Zhou W; Sun J; Ou G; Zhong NS; Liu Z
    Am J Chin Med; 2022; 50(2):351-369. PubMed ID: 35232329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.
    Zhang J; Li Q; Cruz Cosme RS; Gerzanich V; Tang Q; Simard JM; Zhao RY
    mBio; 2021 Feb; 13(1):e0016922. PubMed ID: 35164548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural Homology-Based Drug Repurposing Approach for Targeting NSP12 SARS-CoV-2.
    Aljuaid A; Salam A; Almehmadi M; Baammi S; Alshabrmi FM; Allahyani M; Al-Zaydi KM; Izmirly AM; Almaghrabi S; Baothman BK; Shahab M
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36431833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.
    Terasaki K; Narayanan K; Makino S
    J Virol; 2023 Jul; 97(7):e0065923. PubMed ID: 37367225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2.
    Yoshimoto FK
    Protein J; 2021 Jun; 40(3):260-295. PubMed ID: 33629236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases.
    Samrat SK; Bashir Q; Zhang R; Huang Y; Liu Y; Wu X; Brown T; Wang W; Zheng YG; Zhang QY; Chen Y; Li Z; Li H
    Emerg Microbes Infect; 2023 Dec; 12(1):2204164. PubMed ID: 37060263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19.
    Perveen S; Khalili Yazdi A; Devkota K; Li F; Ghiabi P; Hajian T; Loppnau P; Bolotokova A; Vedadi M
    SLAS Discov; 2021 Jun; 26(5):620-627. PubMed ID: 33423577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An atomistic model of the coronavirus replication-transcription complex as a hexamer assembled around nsp15.
    Perry JK; Appleby TC; Bilello JP; Feng JY; Schmitz U; Campbell EA
    J Biol Chem; 2021 Oct; 297(4):101218. PubMed ID: 34562452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthetic Platforms for Characterizing and Targeting of SARS-CoV-2 Genome Capping Enzymes.
    Ornelas MY; Thomas AY; Johnson Rosas LI; Scoville RO; Mehta AP
    ACS Synth Biol; 2022 Nov; 11(11):3759-3771. PubMed ID: 36331143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Docking study of chloroquine and hydroxychloroquine interaction with RNA binding domain of nucleocapsid phospho-protein - an
    Amin M; Abbas G
    J Biomol Struct Dyn; 2021 Aug; 39(12):4243-4255. PubMed ID: 32469265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics.
    Pérez-Vargas J; Shapira T; Olmstead AD; Villanueva I; Thompson CAH; Ennis S; Gao G; De Guzman J; Williams DE; Wang M; Chin A; Bautista-Sánchez D; Agafitei O; Levett P; Xie X; Nuzzo G; Freire VF; Quintana-Bulla JI; Bernardi DI; Gubiani JR; Suthiphasilp V; Raksat A; Meesakul P; Polbuppha I; Cheenpracha S; Jaidee W; Kanokmedhakul K; Yenjai C; Chaiyosang B; Teles HL; Manzo E; Fontana A; Leduc R; Boudreault PL; Berlinck RGS; Laphookhieo S; Kanokmedhakul S; Tietjen I; Cherkasov A; Krajden M; Nabi IR; Niikura M; Shi PY; Andersen RJ; Jean F
    Antiviral Res; 2023 Jan; 209():105484. PubMed ID: 36503013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.